1. Home
  2. AWRE vs GDTC Comparison

AWRE vs GDTC Comparison

Compare AWRE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • GDTC
  • Stock Information
  • Founded
  • AWRE 1986
  • GDTC 2018
  • Country
  • AWRE United States
  • GDTC Singapore
  • Employees
  • AWRE N/A
  • GDTC N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • GDTC Health Care
  • Exchange
  • AWRE Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • AWRE 50.3M
  • GDTC 21.5M
  • IPO Year
  • AWRE 1996
  • GDTC 2023
  • Fundamental
  • Price
  • AWRE $2.71
  • GDTC $1.88
  • Analyst Decision
  • AWRE
  • GDTC Buy
  • Analyst Count
  • AWRE 0
  • GDTC 1
  • Target Price
  • AWRE N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • AWRE 49.9K
  • GDTC 14.8K
  • Earning Date
  • AWRE 10-29-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • AWRE N/A
  • GDTC N/A
  • EPS Growth
  • AWRE N/A
  • GDTC N/A
  • EPS
  • AWRE N/A
  • GDTC N/A
  • Revenue
  • AWRE $16,146,999.00
  • GDTC $368,838.00
  • Revenue This Year
  • AWRE N/A
  • GDTC $5.37
  • Revenue Next Year
  • AWRE N/A
  • GDTC N/A
  • P/E Ratio
  • AWRE N/A
  • GDTC N/A
  • Revenue Growth
  • AWRE N/A
  • GDTC N/A
  • 52 Week Low
  • AWRE $1.35
  • GDTC $1.20
  • 52 Week High
  • AWRE $2.95
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 58.28
  • GDTC 46.04
  • Support Level
  • AWRE $2.71
  • GDTC $1.82
  • Resistance Level
  • AWRE $2.95
  • GDTC $2.28
  • Average True Range (ATR)
  • AWRE 0.18
  • GDTC 0.12
  • MACD
  • AWRE 0.04
  • GDTC 0.00
  • Stochastic Oscillator
  • AWRE 71.76
  • GDTC 13.04

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: